Edition:
United States

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

73.27USD
23 Apr 2018
Change (% chg)

$-0.42 (-0.57%)
Prev Close
$73.69
Open
$74.17
Day's High
$74.80
Day's Low
$72.95
Volume
115,103
Avg. Vol
224,505
52-wk High
$82.68
52-wk Low
$30.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -1.444
Sep '17 0.00 -1.860
Jun '17 0.00 -1.918
Mar '17 0.00 -1.797
FY 2016 Dec '16 0.00 -1.284
Sep '16 0.00 -0.772
Jun '16 0.00 -0.623
Mar '16 0.00 -0.647
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 0.00 0.00 0.00 --
Quarter Ending Sep-18 5 0.00 0.00 0.00 --
Year Ending Dec-18 10 32.00 220.00 0.00 9.37
Year Ending Dec-19 9 55.56 250.00 0.00 156.68
Earnings (per share)
Quarter Ending Jun-18 10 -1.53 -1.20 -1.93 --
Quarter Ending Sep-18 10 -1.39 -1.11 -1.61 --
Year Ending Dec-18 13 -5.24 2.28 -6.99 -4.98
Year Ending Dec-19 10 -5.08 -1.34 -6.74 -1.62
LT Growth Rate (%) 1 26.60 26.60 26.60 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 185.04 32.78
P/E High - Last 5 Yrs. -- 284.68 45.94
P/E Low - Last 5 Yrs. -- 95.75 24.95
Beta 2.51 0.75 0.80
Price to Sales (TTM) -- 136.40 7.08
Price to Book (MRQ) 7.52 19.34 5.00
Price to Tangible Book (MRQ) 7.94 24.06 6.75
Price to Cash Flow (TTM) -- 122.96 25.60
% Owned Institutions 98.50 11.18 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.55
Dividend Yield - 5 Year Avg -- 0.20 0.74
Dividend 5 Year Growth Rate -- 1.94 3.92
Payout Ratio(TTM) -- 9.18 20.28

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 103.99 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 80.63 10.85
Sales - 5 Yr. Growth Rate -- 33.87 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -12.45 -66.82 22.25
EPS (TTM) vs TTM 1 Yr. Ago -111.06 -- --
EPS - 5 Yr. Growth Rate -- 47.44 10.24
Capital Spending - 5 Yr. Growth Rate 22.89 45.48 10.39

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.53
Current Ratio (MRQ) 6.15 5.97 3.62
LT Debt to Equity (MRQ) 0.00 23.32 11.28
Total Debt to Equity (MRQ) 0.43 25.75 13.94
Interest Coverage (TTM) -202.53 -181.71 30.08

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 36.28 53.98
Gross Margin - 5 Yr. Avg. -- 55.36 52.10
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -149.35 15.94
Operating Margin (TTM) -- -564.83 4.32
Operating Margin - 5 Yr. Avg. -- -161.27 11.31
Pre-Tax Margin (TTM) -- -537.64 4.97
Pre-Tax Margin - 5 Yr. Avg. -- -168.32 11.62
Net Profit Margin (TTM) -- -526.60 1.58
Net Profit Margin - 5 Yr. Avg. -- -168.70 7.94
Effective Tax Rate (TTM) -- -0.44 31.27
Effective Tax Rate - 5 Yr. Avg. -- 18.13 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,918,133 819,537,692
Net Income/Employee (TTM) -2,929,614 754,796 96,346,718
Receivable Turnover (TTM) -- 6.24 5.57
Inventory Turnover (TTM) -- 2.37 3.45
Asset Turnover (TTM) 0.00 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -63.85 -0.77 10.55
Return on Assets - 5 Yr. Avg. -39.14 0.69 11.58
Return on Investment (TTM) -70.41 -0.74 13.21
Return on Investment - 5 Yr. Avg. -41.73 4.20 14.99
Return on Equity (TTM) -70.56 -2.80 15.01
Return on Equity - 5 Yr. Avg. -42.93 -0.05 16.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -109.79 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Esperion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.06 1.61 99 7
13 Week -5.98 -0.25 99 64
26 Week 61.03 54.68 99 89
52 Week 99.70 75.65 99 77
YTD 11.28 11.42 99 87
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 98.49%
# of Holders: 219
Total Shares Held: 26,348,358
3 Mo. Net Change: -770,059
# New Positions: 3
# Closed Positions: 3
# Increased Positions: 14
# Reduced Positions: 18
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.